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Objectives: To assess the efficacy of multiphasic CT with 8 min delayed acquisition in the
differential diagnosis between pleomorphic adenomas and other parotid neoplasias.
Methods: Between January 2004 and April 2007, 62 patients with parotid enlargement were
enrolled in this prospective study. The CT protocol applied included the following four
acquisitions: without contrast medium and 30 s, 120 s and 8 min after intravenous injection
of contrast medium. We considered the degree of the enhancement of the lesions (rated as
‘‘low’’, ‘‘moderate’’ and ‘‘strong’’) and the degree of enhancement homogeneity (rated as
‘‘not homogeneous’’, ‘‘mildly homogeneous’’ and ‘‘uniform’’). These parameters were
compared with Hounsfield values of the lesions computed in each phase. The diagnosis was
confirmed in all patients after surgery.
Results: On histological examination, 36 tumours were classified as pleomorphic adenomas
and 26 as non-pleomorphic adenomas. On the basis of a statistical comparison, the third
phase proved to be the most effective in the differential diagnosis between pleomorphic
adenoma and non-pleomorphic adenomas, both for the assessment of the degree of the
enhancement (in this phase, strong enhancement showed a sensitivity of 61.11%, specificity of
100%, positive predictive value (PPV) of 100% and negative predictive value (NPV) of
53.33%) and, above all, for the homogeneity of the enhancement (in this phase, indeed,
uniform enhancement showed sensitivity, specificity, PPV and NPV of 100%).
Conclusions: Our results seem to indicate that multiphasic CT with 8 min delayed
acquisition allows the differential diagnosis between pleomorphic adenomas and other
parotid neoplasias.
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Introduction
Pleomorphic adenoma is the most common tumour of
the salivary glands. Due to its benign nature, surgeons
can perform minimally invasive surgery.1,2
The differential diagnosis with other forms of
neoplasia, such as carcinomas, Warthin’s tumours and
metastasis, is necessary to determine the best therapeu-
tic approach, since different pathologies require differ-
ent therapies.3,4
Today, multislice CT is one of the primary imaging
modalities used to assess tumours of the salivary
glands. It allows the detection of lesions and assessment
of their extension and characteristics as well as their
relationships to nearby structures.5–7
However, this technique has some limitations linked
to the pathological classification of the tumour. In
relation to this, higher accuracy levels might be
obtained through a multiphasic acquisition with an
8 min delayed phase after contrast administration.
The aim of this study was to assess the efficacy of
multiphasic CT with the 8 min delayed acquisition in
the evaluation of the enlargement of salivary glands
and, in particular, in the differential diagnosis between
pleomorphic adenomas and other parotid lesions.
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Materials and methods
During a period of 3 years (January 2004 to April 2007)
62 patients (28 women and 34 men; with age range 25–
80 years and mean age 50) with clinically tested parotid
enlargement underwent CT examination.
The histopathological diagnosis was confirmed in all
patients after surgery or ‘‘open sky’’ biopsy.
Examinations were carried out with the four-layer
Philips CT. The technical protocol applied to all of the
examinations included the following four acquisitions:
(a) without contrast medium; (b) in the early phase,
30 s after intravenous injection of non-ionic contrast
material (90 ml) at 3 ml s21; (c) a delayed scan (120 s
scan delay); (d) a further delayed phase, after 8 min.
Pre-contrast and early scans targeted the skull base,
going through the superior thoracic outlet with the
following parameters: 35 s acquisition time, 3 mm
collimation and 3 mm s21 table feed. To increase
radiation protection, the volume acquisition was
reduced to the area of the lesion in the last two phases.
The total radiation dose received by the patients was
not higher than the amount received during traditional
biphasic techniques without reduction of the volume
acquisition. Written informed consent was obtained
before each examination, to meet transparency needs.
Each CT scan was assessed by three experienced
radiologists who were blinded to the histological
results. Each radiologist evaluated the results autono-
mously and assessed, for each phase, the degree and
homogeneity of the enhancement of the lesion.
The degree of the enhancement was rated as ‘‘low’’,
‘‘moderate’’ or ‘‘strong’’, while the degree of homo-
geneity was rated as ‘‘not homogeneous’’, ‘‘mildly
homogeneous’’ or ‘‘uniform’’.
Each lesion’s Hounsfield value (HU) was determined
in each phase, computed by drawing a region of interest
(ROI) around the entire area (7–32 mm2).
Wide ROIs were used, avoiding cystic and necrotic
areas which are frequently present in benign and
malignant parotid lesions.
This is necessary during the subjective assessment of
the degree and homogeneity of the enhancement of the
lesions because the presence of cystic and necrotic areas
can modify the homogeneity of enhancement of solid
areas.
From this point of view, a lesion with a ‘‘not
homogeneous’’ density may also have a homogeneous
enhancement.
Lesions with Hounsfield values under 70 HU were
rated as having a ‘‘low’’ degree of enhancement; a
‘‘moderate’’ degree ranged between 70 HU and 90 HU
and a ‘‘strong’’ degree was above 90 HU.
At the end, the statistical significance of the most
common degree and homogeneity patterns of the
enhancement of pleomorphic adenoma during each
phase were compared to determine the most useful
post-contrast phase in the differential diagnosis
between pleomorphic adenoma and other parotid
lesions (cited in the text as ‘‘non-pleomorphic ade-
noma’’).
Results
Out of 62 histologically confirmed parotid tumours,
36 were pleomorphic adenomas, 15 Warthin’s tumours,
5 squamous cell carcinomas, 3 mucoepidermoid
tumours and 3 acinic cell carcinomas.
The maximum transversal diameter of the lesions
ranged from 10 mm to 50 mm (average 24 mm); no
statistically significant differences were detected among
the various histological tumour types in relation to
dimension.
In all three phases, the radiologists obtained the same
results both for degree and for homogeneity of the
enhancement.
Results related to degree, homogeneity of enhance-
ment and HU values in each phase are summarized in
Table 1.
As to the degree of enhancement, the most sensitive
pattern of pleomorphic adenoma in the first post-
contrast phase was low enhancement (25 out of
36 pleomorphic adenomas), also detected in 4 out of
26 non-pleomorphic adenomas (all malignant lesions).
In the second post-contrast phase, the most common
pattern of pleomorphic adenoma was moderate
enhancement (22 out of 36); this was detected in 9 of
26 non-pleomorphic adenomas in the same phase.
In the third post-contrast phase, the most common
pattern of pleomorphic adenoma was strong enhance-
ment (22 of 36); in this phase, it was not detected in
non-pleomorphic adenomas.
With respect to the homogeneity of the enhancement,
the most common pattern of pleomorphic adenoma in
the first post-contrast phase was the ‘‘not homoge-
neous’’ (28 of 36), detected also in 5 of 26 non-
pleomorphic adenomas.
In the second post-contrast phase, the most common
pattern of pleomorphic adenoma was, again, the ‘‘not
homogeneous’’ phase (19 of 36), also detected in 8 out
of 26 non-pleomorphic adenomas.
In the third post-contrast phase, all pleomorphic
adenomas showed a uniform enhancement (36 of 36);
this pattern was not detected in non-pleomorphic
adenomas.
These patterns were the most significant for each
post-contrast phase for the differential diagnosis
between pleomorphic adenomas and non-pleomorphic
adenomas (Figures 1–3). On the basis of a statistical
comparison, the third phase proved to be the most
effective both for the assessment of the degree of the
enhancement (in this phase strong enhancement
showed sensitivity of 61.11%, specificity of 100%,
positive predictive value (PPV) of 100% and negative
predictive value (NPV) of 53.33%; see Table 2) and,
above all, for the homogeneity of the enhancement (in
the third phase, indeed, uniform enhancement showed
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a b c d
Figure 1 Axial CT scan of a typical parotid pleomorphic adenoma, obtained (a) initially and then (b) 30 s, (c) 120 s and (d) 8 min after
intravenous administration of contrast material. Note progressive increment of degree and homogeneity of the enhancement; it becomes strong
and homogeneous in (d) the second late phase
a b c d
Figure 2 Axial CT scan of a typical parotid pleomorphic tumour, obtained (a) initially and then (b) 30 s, (c) 120 s and (d) 8 min after
intravenous administration of contrast material. Another case of parotid pleomorphic adenoma with characteristic delayed enhancement
Table 1 Different behaviour of enhancement among the histological types of parotid enlargements
Histology Phase
Degree Homogeneity
Low ,70 HU
Moderate
70–90 HU Strong .90 HU
Not
homogeneous
Mildly
homogeneous Uniform
Pleomorphic
adenoma
(n5 36)
Early 25 (69.4%) 11 (30.6%) 0 28 (77.8%) 8 (22.2%) 0
Delayed 1 15 (41.7%) 21 (58.3%) 0 19 (52.8%) 17 (47.2%) 0
Delayed 2 0 14 (38.9%) 22 (61.1%) 0 0 36 (100%)
Warthin’s
tumours
(n5 15)
Early 0 7 (46.6%) 8 (53.4%) 2 (13.4%) 8 (53.3%) 5 (33.3%)
Delayed 1 8 (53.3%) 6 (40.0%) 1 (6.7%) 6 (40.0%) 8 (53.3%) 1 (16.7%)
Delayed 2 12 (75.0%) 3 (25.0%) 0 8 (53.3%) 7 (46.7%) 0
Malignant
lesions (n5 11)
Early 4 (36.3%) 2 (18.2%) 5 (45.5%) 3 (27.2%) 4 (36.4%) 4 (36.4%)
Delayed 1 2 (18.2%) 3 (50.0%) 6 (33.0%) 2 (18.3%) 6 (54.5%) 3 (27.2%)
Delayed 2 5 (45.5%) 6 (54.5%) 0 3 (27.2%) 8 (72.8%) 0
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sensitivity, specificity, PPV and NPV of 100%; see
Table 3).
Discussion
Pleomorphic adenoma is the most common tumour of
the salivary glands;8 generally, it is a benign and slow-
growing tumour. It is more frequent in women than in
men and has a peak incidence at 40 years.8 From the
anatomopathological point of view, the pleomorphic
adenoma shows a variegated pattern due to the
presence of areas with epithelial differentiation (solid
adenoid areas) and areas with mesenchymal-like
differentiation (chondroid myxoid areas).9
It is often surrounded by a capsule (not always
intact) and sometimes it has satellite micronodules.10
Due to the presence of multifocal lesions, total
parotidectomy with preservation of the facial nerve is
the most common therapy to avoid post-surgical recur-
rences.1 In the long term, a malignant degeneration may
occur; this is more likely in adenomas older than 10 years.
Therefore, early diagnosis is necessary and should be
followed by the appropriate therapeutic approach.6
The literature includes studies that characterize parotid
lesions on the basis of their behaviour after contrast
administration, through study protocols developed on
two dynamic phases (30 s and 120 s scan delay).11
Results were not completely satisfying; they showed
that during the 120 s delayed phase, adenomas showed
a modest enhancement increase; Warthin’s tumours
showed a decrease and malignant tumours showed an
increase or no change at all.
Other authors have recently used more delayed
phases to better study parotid lesions: the pathogno-
monic behaviour of the pleomorphic adenoma enhance-
ment was already clear, becoming stronger and more
homogeneous in delayed phases.12,13
a b c d
Figure 3 Axial CT scan of a typical parotid Warthin’s tumour, obtained (a) initially and then (b) 30s, (c) 120s and (d) 8 min after intravenous
administration of contrast material. Enhancement is strong and homogeneous in (b) the first post-contrast phase; it becomes weak/moderately
homogeneous in (d) the second late phase
Table 2 The best homogeneity pattern of the enhancement of pleomorphic adenoma in each phase: a statistical evaluation in the differential
diagnosis between pleomorphic adenoma and non-pleomorphic adenomas
Time after
contrast injection
Most sensitive homogeneity of
enhancement pattern of pleomorphic
adenoma Specificity (%) PPV (%) NPV (%)
30 s Not homogeneous 77.7% (28/36) 68.75 84.85 57.89
120 s Not homogeneous 52.77% (19/36) 50.00 70.37 32.00
8 min Uniform 100% (36/36) 100 100 100
PPV, positive predictive value; NPV, negative predictive value
Table 3 The most sensitive degree pattern of the enhancement of pleomorphic adenoma in each phase: a statistical evaluation in the differential
diagnosis between pleomorphic adenomas and non-pleomorphic adenomas
Time after contrast
injection
Most sensitive degree of enhancement
pattern of pleomorphic adenoma Specificity (%) PPV (%) NPV (%)
30 s Low 69.44% (25/36) 75.00 86.20 52.17
120 s Moderate 58.33% (21/36) 56.25 70.00 31.81
8 min Strong 61.11% (22/36) 100 100 53.33
PPV, positive predictive value; NPV, negative predictive value
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Our study aimed at investigating the interesting hints
from the literature and at enrolling more patients to
confirm the usefulness of this three-phase study, followed
by a delayed phase for the assessment of parotid lesions.
On the basis of our experience, triphasic CT of
parotid tumours was more useful than biphasic
examination for characterizing lesions. The first tech-
nique, indeed, provides a better differentiation of the
anatomopathological characteristics between pleo-
morphic adenomas and non-pleomorphic adenomas.
In particular, the hypovascularization of pleo-
morphic adenomas was better assessed; it is responsible
for the delay by which the enhancement of the lesions
becomes strong and homogeneous.
Data from the early phase proved to be reliable only
in ruling out the pleomorphic adenoma in cases in
which the enhancement of the lesion was strong and
uniformly homogeneous.
In all other cases, the diagnosis was doubtful; it was
not even possible to differentiate between benign and
malignant lesions.
The analysis of the lesions’ enhancement patterns in the
first delayed phase allowed us to rule out the diagnosis of
pleomorphic adenoma when the degree and homogeneity
of the enhancement were reducing. However, it was not
possible to discriminate with high specificity the pleo-
morphic adenoma from malignant tumours in cases
where the degree and homogeneity of the enhancement
either increased or remained unchanged.
Thus, the second delayed phase proved to be extremely
useful; it clearly showed the difference between pleo-
morphic adenomas and malignant tumours.
In adenomas, enhancement was always stronger and
more homogeneous while malignant tumours (more
vascularized) showed an opposite trend.
Table 2 shows the statistical value of the most frequent
degree and homogeneity patterns of the enhancement of
pleomorphic adenoma in each phase, to identify the most
effective phase for the differential diagnosis between
pleomorphic adenoma and other adenomas.
Results clearly show that the 8 min after contrast
administration phase is the most effective phase for the
differential diagnosis between pleomorphic adenoma
and non-pleomorphic adenomas; strong enhancement
and uniform enhancement, indeed, showed specificity,
PPV and NPV values higher than the most sensitive
patterns of pleomorphic adenoma obtained in the other
two post-contrast phases.
In particular, the best accuracy pattern was uniform
enhancement because (according to its PPV and NPV
of 100%) its presence/absence allowed a certain
differential diagnosis.
This result entails important implications not only
for the radiological evaluation of the lesions (i.e.
examining CT scans knowing it is a benign lesion),
but also for the diagnosis, to avoid unnecessary biopsies
and to clear up potential doubts from the biopsy in the
event of sampling mistakes or atypical histological
variances.
This technical protocol can be particularly useful in
the case of lesions located in the deep extension of the
parotid gland; these lesions could not be assessed by
ultrasound and, due to their location, the biopsy was
not easy to perform.14
As previously said, the results from the three
radiologists were the same in all three phases both for
the degree and homogeneity of the enhancement,
proving that the study can be easily reproduced.
The subjective assessment of the degree and homo-
geneity of the enhancement in the different phases was
confirmed by the empirical assessment of the CT
number of lesions by drawing a region of interest.
The confirmation of correspondence of the degree
(low, moderate, strong) and of the homogeneity of
enhancement (low, moderate, uniform) to numerical
values provides the subjective analysis of CT examina-
tions with objective data confirming the radiologist’s
personal opinion.
On the basis of our results, obtained on the broadest
population reported in literature regarding CT parotid
studies, we think that our technique might represent the
basis for the improvement of this technical protocol to
be regularly applied in CT examinations of parotid
enlargements.
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